Zoetis Thailand lands two wins at Asian Management Excellence Awards 2026

The company won Thailand Innovator of the Year - Pharmaceuticals and the Thailand Team of the Year - Pharmaceuticals.

Zoetis Thailand was honoured at the prestigious Asian Management Excellence Awards 2026 for delivering double-digit market share growth, deep penetration in key accounts, and strong customer loyalty through innovative platforms, stronger veterinary partnerships, and enhanced loyalty programmes.

The company has set itself apart in the market by delivering superior value, trusted support, and ongoing educational initiatives. A major driver of this success is the introduction of Unbox IMAGYST to key opinion leader groups—an artificial intelligence (AI)-enabled, in-clinic diagnostic platform. Unbox IMAGYST dramatically accelerates diagnostic turnaround time, reducing wait periods from up to seven days with referral laboratories to same-day results, thereby enhancing clinical efficiency and customer satisfaction.

Launched under the leadership of Companion Animal Diagnostic Lead Orapat Kaewthumchai, IMAGYST stands out as a truly unique innovation in the Thai market. Its launch and adoption model is comprehensive and difficult to replicate, combining Thai-language training, hands-on onboarding, integrated workflows, pathologist support, and a disciplined 90-day enablement programme.

Built on VS2 and HM5 success, we will use the same approach for IMAGYST: clinician education with Thai-language CPD and KOL webinars, structured training and 90-day onboarding, in-clinic workflow mapping and SOPs, pathologist engagement for case confidence, and responsive post-install support. This model standardises clinic adoption, strengthens performance and data quality, and will expand AI-enabled, in-clinic workflows for clearer results and better medicine.

Operational efficiency is also maximised through seamless onboarding, comprehensive training, and ongoing support, ensuring clinics can fully leverage the system’s capabilities.

“The Zoetis Thailand Companion Diagnostics team stands as a model of repeatable, scalable innovation, transforming clinical practice, strengthening business performance, and delivering measurable benefits for veterinarians, pets, and clinics across Thailand,” the company said.

Kaewthumchai and the Diagnostics team received the Thailand Innovator of the Year - Pharmaceuticals in the awards programme for this revolutionary approach.

Beyond trusted partner

Meanwhile, its Companion Animal Business (CBU) Sales and Marketing Team has also achieved a major turnaround in 2025. After facing competitive pressures, shifting customer preferences, economic uncertainties, and supply chain disruptions in 2024, the business unit has used these challenges as a foundation for transformation.

The team has launched the “Beyond Trusted Partner” strategy, which focuses on strengthening loyalty programmes, driving business transformation, and launching impactful products. The strategy has been executed through a 360° Excellence Marketing, which has integrated digital campaigns, targeted field activation, and robust veterinary partnerships.

Key opinion leaders and high-impact events have anchored the approach, delivering education and loyalty in priority segments. Real-time dashboards have enabled campaign optimisation, whilst listening sessions with clinics have shaped tailored solutions.

As a result, the CBU Team has achieved 17.1% YoY growth, far exceeding the 9.7% market growth. Parasiticide sales have also rebounded by 26.4%— twice the market growth rate— driven by integrated campaigns and field activation. Flagship brands such as Simparica Trio, Revolution Plus, and APOQUEL have also delivered sustained double-digit growth, reinforcing leadership in companion animal care.

The team has also led Thailand’s first launch of a deep learning AI diagnostic solution for companion animals, advancing clinical accuracy and efficiency. SOLENSIA, in particular, has expanded feline osteoarthritis treatment opportunities, raised standards of care and improved patient outcomes.

“CBU’s journey from 2024 to 2025 highlights dedication to business impact, veterinary innovation, and workforce engagement, building trust, driving turnaround, and creating lasting value for the companion animal health community,” the company said.

For this achievement, the CBU Team was hailed as the Thailand Team of the Year - Pharmaceuticals.

The Asian Management Excellence Awards celebrates the finest business leaders, innovators, and companies in Asia, recognising exceptional achievements in employee engagement programmes, diversity and inclusion projects, and health and wellness initiatives.

The Asian Management Excellence Awards is presented by Asian Business Review Magazine. To view the full list of winners, click here. If you want to join the 2027 awards programme and be acclaimed for your company's employee engagements and management initiatives, please contact Danica Avila at [email protected].